Download Roadmap The healthcare sector, while focused on improving human health, is a contributor to environmental impacts.

Dublin, Ireland-based Jazz Pharmaceuticals derives the majority of its revenues from its sleep disorder drugs, Xywav and Xyrem. The company also has several ongoing and planned development activities ...

The shift from fossil fuels to renewable energy continues to gain momentum as global efforts to reduce greenhouse gas emissions ... rising from 2.4 gigawatts (GW) in 2000 to 154.6 GW in 2024.

A backlog of delayed projects led to a record 148.1% surge in 2023, raising new capacity to 216.88 GW. Despite this, 2024 saw further growth, with installations up 28.3% to 277.57 GW, pushing ...

In 2021, the company acquired GW Pharmaceuticals for $7.2bn, gaining the seizure medication Epidiolex (cannabidiol). In February 2024, it licensed a KRAS inhibitor programme from UK-based Redx ...

though administrators labeled one protest of the Israel-Hamas conflict as an “illegal and potentially dangerous occupation of GW property.” The university claimed that demonstration included ...

Global offshore wind is gearing up for a comeback in 2025, with new capacity additions expected to hit 19 gigawatts (GW) and spending projected to soar to $80 billion, according to Oslo-based ...

KEARNEY, Mo. (KCTV) - The former manager of a Kearney greenhouse has been charged in connection to a years-long $150,000 embezzlement scheme. Clay County, Missouri, Circuit Court records filed on ...

JSW Energy's acquisition of assets from O2 Power and Hetero Group, along with a thermal power asset, has increased its capacity to meet a 20 GW target by 2028, two years ahead of schedule. The company ...